SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending after Hapag-Lloyd confirmed an agreement to acquire the shipping company for $35 per share, prompting community discussion about potential dividends before the expected 2026 closing. Many are eyeing a potentially higher final price due to the company's perceived undervaluation, geopolitical considerations, and the possibility of a short squeeze.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending as a 'Pure Belief Asset' driven by a passionate community's 'Resist & Retire' movement, challenging traditional financial systems through memes and active building. Its growing presence on platforms like Coinbase and in top crypto subreddits highlights its anti-establishment appeal amidst prevailing market volatility.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending due to active arbitrage plays stemming from its proposed acquisition by Kimberly-Clark below the offer price, while widespread community debate surrounds ongoing lawsuits alleging Tylenol's link to autism, with many dismissing these claims as politically driven.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium is actively discussed following recent regulatory clarity and a new AT&T partnership, with the community closely watching its consolidating tokenomics as rewards shift to HNT, reinforcing its position within the growing DePIN sector.

MasTec, Inc. engages in the provision of infrastructure construction services. It operates through the following segments: Communications, Oil and Gas, Clean Energy and Infrastructure, and Other. The Communications segment performs engineering, construction, maintenance, and customer fulfillment activities related to communications infrastructure, primarily for wireless and wireline/fiber communications, and install-to-the-home customers. The Oil and Gas segment offers services on oil and natural gas pipelines and processing facilities for the energy and utilities industries. The Clean Energy and Infrastructure segment serves energy, utility and other end-markets through the installation and construction of power generation facilities, including from clean energy and renewable sources such as wind, solar and biomass, as well as various types of heavy civil and industrial infrastructure. The Other segment consists of equity investors, other small business units that perform construction, and other services for a variety of international end-markets. The company was founded by Jorge Mas Canosa on July 26, 1968, and is headquartered in Coral Gables, FL.

Mastec Inc.

MasTec is gaining traction from strong recent earnings and an elevated outlook, driven by robust demand in its communications and power delivery segments, particularly benefiting from the AI-driven data center infrastructure boom. The community is actively discussing its momentum as an "old economy" stock thriving on significant infrastructure spending and a record backlog.

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Celldex Therapeutics Inc.

Celldex Therapeutics is trending following strong clinical data for its lead drug barzolvolimab in chronic urticaria, with the community anticipating it as a potential best-in-class treatment or buyout target despite ongoing discussions about its safety profile and long development timeline.

Tidal Trust II - YieldMax HOOD Option Income Strategy ETF

YieldMax HOOD Option Income Strategy ETF

YieldMax HOOD Option Income Strategy ETF (HOOY) is a top talking point for its new weekly distribution schedule, as investors weigh its attractive high yield against persistent community concerns about potential capital depreciation, all while keeping an eye on the underlying HOOD's market performance.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is buzzing with anticipation for imminent Phase 3 data readouts for its COMP360 psilocybin therapy, as accelerated commercial launch plans and FDA clearance for PTSD trials position it as a potential first-to-market leader in addressing treatment-resistant depression.

Green Plains, Inc. engages in the production of fuel-grade ethanol and corn oil, the provision of grain handling, and storage commodity marketing and distribution services. It operates through the following segments: Ethanol Production and Agribusiness and Energy Services. The Ethanol Production segment produces ethanol, distillers' grain, and corn oil at ethanol plants in Indiana, Iowa, Minnesota, Nebraska, Tennessee, and Texas. The Agribusiness and Energy Services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, renewable corn oil, natural gas and other commodities. The company was founded in June 2004 and is headquartered in Omaha, NE.

Green Plains Inc

Green Plains Inc. is trending amid activist investor Ancora's call for the company to explore a sale, fueling community discussion on its strategic future. This comes as the company highlights significant advancements in carbon capture and securing 45Z clean fuel tax credits, which are seen as pivotal for its low-carbon growth trajectory.

Renaissance Capital Greenwich Funds - Renaissance International IPO ETF

The Renaissance International IPO ETF ($IPOS) is garnering significant attention from retail investors, with sustained chatter across social media platforms discussing its performance and notable option activity. This ETF remains a focal point for those looking to gauge or capitalize on the dynamic landscape of international initial public offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 26, 2026, following the release of its fourth...

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of +22.25% and +2.39%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Universal Beteiligungs und Servicegesellschaft mbH Buys 159,200 Shares of Puma Biotechnology, Inc. $PBYI

Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 405.0% during the 3rd quarter, according to its most recent 13F filing...

New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand

New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free...

Zacks Research Issues Pessimistic Forecast for PBYI Earnings

Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Equities researchers at Zacks Research decreased their Q1 2027 earnings estimates for Puma Biotechnology in a research report issued to clients...

Ritholtz Wealth Management Raises Stake in Puma Biotechnology, Inc. $PBYI

Ritholtz Wealth Management lifted its holdings in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 139.0% during the third quarter, according to its most recent disclosure with the Securities...

Puma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200 Day Moving Average - What's Next?

Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200-Day Moving Average - What's Next...

Puma Biotechnology (NASDAQ:PBYI) Shares Cross Above 200 Day Moving Average - Here's What Happened

Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above 200-Day Moving Average - Time to Sell...

Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective at the close of trading on Friday...

CRMD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Buy?

CorMedix's DefenCath sales and Melinta deal raise growth stakes while Puma Biotechnology's Nerlynx-led breast cancer franchise aids growth.

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Puma Biotechnology Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

PBYI
Puma Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PBYI News

PBYIPuma Biotechnology Inc